3 unknown, 2 completed, 1 not yet recruiting. 2 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Bismuth Subcitrate: new trials by email Literature Review of Bismuth Subcitrate trials Research Report on Bismuth Subcitrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication Metronidazole, Tinidazole 500mg, tetracyline - Helicobacter Pylori Infection | Not applicable | Not yet recruiting | University of Medicine and Pharmacy at Ho Chi Minh City | 600 | 2026-07-27 | 2026-08-05 |
| Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection Bismuth Subcitrate, Esomeprazole, Metronidazole - Helicobacter Pylori Infection | Unknown | National Institute of Public Health, Slovenia | 2000 | 2024-02-01 | 2024-02-09 | |
| Bismuth Quadruple Therapy Versus Standard Triple Therapy Bismuth Subcitrate - Helicobacter Pylori Infection | Phase 4 | Unknown | University Medical Centre Ljubljana | 216 | 2022-03-03 | 2023-11-22 |
| Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. Pantoprazole 40mg, Amoxicillin 1000 MG, Clarithromycin 500mg - Helicobacter Pylori Infection, Antibiotic Resistant Infection | Phase 3 | Unknown | University of Bari | 362 | 2020-01-14 | 2021-01-12 |
| Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication Bismuth quadruple therapy, Hybrid therapy - Helicobacter Pylori Infection | Not applicable | Completed | Kaohsiung Veterans General Hospital. | 330 | 2013-07-01 | 2017-11-24 |
| Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma bismuth subcitrate, amoxicillin, clarithromycin - Lymphoma | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 96 | 1997-09-01 | 2012-07-02 |
Drug-Related Side Effects and Adverse Reactions (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1) · Stomach Neoplasms (1)
European Organisation for Research and Treatment of Cancer - EORTC (1) · Kaohsiung Veterans General Hospital. (1) · National Institute of Public Health, Slovenia (1) · University Medical Centre Ljubljana (1) · University of Bari (1) · University of Medicine and Pharmacy at Ho Chi Minh City (1)
Slovenia (2) · Italy (1) · United Kingdom (1) · Vietnam (1)
John W. Sweetenham, MD (1) · Mariabeatrice Principi, Prof. (1) · Patrice P. Carde, MD (1) · Ping-I Hsu, Bachelor (1)
PMID 21188333, PMID 22958155, PMID 27144617, PMID 27687850, PMID 27707777, PMID 28541262, PMID 28653787, PMID 28807915, PMID 30038469, PMID 41830631